Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue TestsPRNewsWire • 09/16/21
Co-Diagnostics, Inc. CEO to Participate in Panel Discussion with Scott Gottlieb, M.D., at H.C. Wainwright 2021 Annual Global Investor ConferencePRNewsWire • 09/13/21
Co-Diagnostics says its Logix Smart COVID-19 Test Kit used to confirm presence of coronavirus including mutated strains in ItalyProactive Investors • 09/08/21
Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in ItalyPRNewsWire • 09/08/21
Co-Diagnostics, Inc. To Present At 13th Next Generation Dx Summit In Washington, D.C.PRNewsWire • 08/23/21
CoDiagnostics, Inc. (CODX) Just Reclaimed the 20-Day Moving AverageZacks Investment Research • 08/16/21
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/13/21
CoDiagnostics, Inc. (CODX) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/12/21
Co-Diagnostics sees 2Q revenue rise by 13.8% driven by sales of the Logix Smart COVID-19 TestProactive Investors • 08/12/21
Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And WebcastPRNewsWire • 08/04/21
Co-Diagnostics strengthens intellectual property portfolio with South Korean patent award for its CoPrimer technologyProactive Investors • 07/22/21
Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer™ PatentPRNewsWire • 07/22/21
Strength Seen in CoDiagnostics, Inc. (CODX): Can Its 9.7% Jump Turn into More Strength?Zacks Investment Research • 07/20/21
Co-Diagnostics, Inc. says its Logix Smart cornavirus test has obtained regulatory authorization to be sold in markets that accept CE markingsProactive Investors • 06/18/21
Co-Diagnostics says it will be presenting virtually at two conferences virtually this weekProactive Investors • 06/15/21